CS Paper Radar

Deep learning-based computed tomography (CT) derived body composition classifier for colorectal cancer patients

Eve Harling, Chattarin Pumtako, Bernd Porr, Donald C McMillan, Ross D Dolan

eess.IV cs.LG ·submitted 2026-08-16 12:33 UTC · v1

Abstract

Background: Accurate body composition analysis using Computed Tomography (CT) scans is essential for assessing skeletal muscle area (SMA) and skeletal muscle density (SMD), key markers of nutritional status in cancer patients. Conventional manual methods are labour-intensive and require specialist expertise, limiting their routine clinical use. Therefore, this study serves as a feasibility and pilot investigation to explore the potential of deep learning-based automated regression for body composition analysis within a clinical workflow. Methods: Four deep learning architectures (AlexNet, UNet, GoogLeNet, and ResNet34) were trained to predict SMA, SMD, subcutaneous fat area (SFA), and visceral fat area (VFA) from CT scans of colorectal cancer patients. Systematic hyperparameter optimization identified the most accurate models, which were subsequently implemented in a web application for clinical use. Results: GoogLeNet achieved the best performance, with a mean percentage error (PE) of 4.96% for SMA prediction, while AlexNet reached 8.12% for SMD. Independent testing demonstrated robust accuracy, correctly classifying body composition metrics in 80% of cases. The web application delivered rapid and consistent outputs, supporting integration into clinical workflows. Conclusion: Optimized deep learning models, particularly GoogLeNet and AlexNet, can automate CT-derived body composition analysis with a Mean Percentage Error (PE) of 4.96% for SMA and 8.12% for SMD. These tools have the potential to streamline clinical practice by reducing the time and expertise required for manual segmentation. Further validation in larger, more diverse datasets is warranted.

Comment
27 pages, 4 figures

Closest papers

Nearest neighbours by meaning across the whole index.

Colorectal Cancer Segmentation with Adaptive Augmentation and Multi-Resolution Ensemble Models

eess.IV cs.AIcs.CV ·2026-09-29 ·Ümit Mert Çağlar, Alptekin Temizel
publishedcode/data similarity 0.67
Abstract · SPIE Eighteenth International Conference on Machine Vision (ICMV 2025), Paris, France

Colorectal cancer (CRC) is the second most deadly and third most common cancer, and the leading cause of death among gastrointestinal cancers. Early diagnosis is crucial for the treatment of this cancer and increasing the survival rates. Although CRC is more common in developed regions, its occurrence is also increasing in developing regions as well. CRC diagnosis relies on histopathology assessment post-biopsy. Automated deep learning algorithms can significantly reduce diagnosis time, enhancing efficiency and supporting timely clinical decisions. We present an automated segmentation pipeline for whole-slide histopathology images that labels tumor grades 1-3 and normal mucosa. It utilizes dense prediction transformers with various encoder backbones, overlapping patches, and test-time augmentation. An adaptive augmentation policy, guided by large language models, further improves training. Top models were ensembled via soft voting, and mask refining post-processing steps, Gaussian blurring, morphological closing, and connected components analysis. On a colorectal cancer grade dataset, our method improved the F1 score from 62.92 to 69.84. Code is available here: github.com/caglarmert/ICIP2025

0.34

Comprehensive Benchmarking of Deep Learning Architectures for Lung Cancer Histopathology

cs.CV cs.AI ·2026-08-16 ·Hadi Hasan, Safaa Salman, Lama Sleem, Ralph Mouawad, Ali Chehab
benchmark similarity 0.66
Abstract · 8 pages

Lung cancer remains the leading cause of cancer-related mortality worldwide, while histopathological diagnosis is often affected by inter-observer variability and the substantial workload associated with manual slide examination. Although deep learning has shown considerable potential in computational pathology, comprehensive benchmarks that integrate tissue classification and region segmentation within a unified analytical framework remain limited. This study presents a two-stage deep learning framework for multi-class tissue classification and pixel-level histopathological region segmentation, accompanied by a systematic comparison of state-of-the-art architectures at each stage. For tissue classification, six models, a custom convolutional neural network, VGG16, DenseNet, MobileNetV3, a custom Vision Transformer, and YOLO11, are evaluated on a combined dataset of 39,000 images derived from LC25000 and LungHist700. The models distinguish between adenocarcinoma, squamous cell carcinoma, and normal lung tissue. YOLO11 achieves the best classification performance, with an accuracy of 98.38%, a five-fold cross-validation accuracy of 98.21 +/- 0.35%, and a macro F1-score of 0.98. For region segmentation, U-Net, ResNet-encoder U-Net, DeepLabV3+, and YOLO11-seg are evaluated using the GlaS gland segmentation benchmark. DeepLabV3+ obtains the highest Intersection over Union of 0.80 and a Dice score of 0.89, while YOLO11-seg achieves a comparable Intersection over Union of 0.79 using approximately 14x fewer parameters. The best-performing classification and segmentation models are subsequently integrated into an end-to-end framework, providing an accurate, computationally efficient, and reproducible baseline for automated histopathological image analysis.

0.40

PCLSegNet: Anatomy-Aware Deep Learning Framework for MRI-based Pancreatic Cyst Segmentation and Size Assessment

cs.CV ·2026-11-11 ·Hanyi Zhang, Tongyu Wang, Manuel Debic, Markus Wennmann, Johannes Haubold +19 more
similarity 0.63
Abstract · 17 pages, 4 figures, 6 tables

Early detection and follow-up of pancreatic cystic lesions (PCLs) are crucial, as some of their subtypes, such as mucinous cystic neoplasms (MCNs) and intraductal papillary mucinous neoplasms, carry a significant risk of malignant transformation. Although most AI studies investigating PCLs rely on computed tomography (CT) scans, magnetic resonance imaging (MRI) offers superior soft tissue contrast, making it highly suitable for PCLs assessment. In this work, we propose an anatomy-aware two-stage deep learning framework for automated PCLs segmentation on abdominal MRI scans. First, a publicly available pancreas segmentation model is used to localize the pancreas. Then, we introduce the anatomyaware PCLSegNet, which incorporates anatomical priors as guidance for pancreas and PCLs segmentation. To address the class imbalance problem, we develop a Class-Specific ErrorWeighted (CSEW) loss function. Postprocessing is applied through anatomical constraints.Our proposed method outperforms multi-organ segmentation models such as TotalSegmentator, achieving substantially higher Dice scores for pancreas segmentation. Moreover, it also achieves a superior normalized surface Dice (NSD) and recall for PCLs segmentationcompared to other state-of-the-art models like nnU-Net, while also notably reducing the false negative rate, facilitating the automatic early detection and the noninvasive imaging-based assessment of PCLs.

0.21

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.63
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19

Targeted Deep Regression - Initial Applications in Whole-Body Water-Fat MRI in UK Biobank

cs.CV cs.LG ·2026-10-26 ·Filip Marttala, Taro Langner, Johan Öfverstedt, Nouman Ahmad, Håkan Ahlström +2 more
similarity 0.61
Abstract · 16 pages, 8 figures

UK Biobank is a British clinical study which, in addition to large amounts of medical data collected, plans to include detailed Magnetic Resonance Imaging (MRI) examina- tions from 100,000 participants. The image data can be analyzed for example by auto- mated analysis with neural networks for image segmentation or classification to expand the collection of image-derived phenotypes for medical research. In this work, we pro- pose, present and evaluate a methodology that uses image-based regression to estimate numerical properties from the collected neck-to-knee water-fat MRI scans. It applies a ResNet50-style network to 2D multi-channel collages that represent targeted and study- specific anatomical sub-regions from the MRI scan. The targeted sub-region sampling is achieved by propagating manually defined subregions from a reference scan to the other >30,000 analyzed scans using image registration. The resulting collages can be compact while retaining high-resolution, for example by providing multiple slices of kidney tissue for a kidney volume regression network. This approach also enables group-wise saliency analysis that highlight image and anatomical regions used by the network for the pre- dictions. The method was applied for the regression endpoints of kidney volume, heart volume, and age. Predictive performance was found between R2 = 0.731-0.984 and the group-wise saliency maps were found to highlight medically relevant regions. We con- clude that the method can be used to standardize and restrict the information presented to a deep regression analysis pipeline, increasing information density and opening up a wide range of future medical inference studies.

0.24

Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy Using Temporal Deep Learning on DWI

cs.AI ·2026-08-18 ·Pablo García Marcos, Md. Tarequl Islam, Paula Puerta González, Guillermo Lorenzo, Héctor Gómez +3 more
similarity 0.60
Abstract

Early identification of non-responders to neoadjuvant chemotherapy (NACT) is crucial for timely treatment adaptation in breast cancer. However, many existing predictive models rely on multiparametric magnetic resonance imaging (MRI), late treatment time points, or extensive clinical data, which limits their applicability. This study proposes a deep learning framework for early prediction of pathological complete response (pCR) using only diffusion-weighted MRI (DW-MRI) acquired at baseline and after the first NACT cycle. This framework feeds cropped tumor-centered patches to an EfficientNet-based temporal model that directly learns tumor shape and local tissue characteristics without explicit radiomic feature engineering. The model, trained with 10-fold cross-validation, achieved an area under the receiver operating characteristic curve (AUC) of 0.90 for pCR prediction after one cycle, providing actionable information after a single treatment cycle while avoiding gadolinium administration and reducing dependence on heterogeneous clinical data. By focusing on the baseline-to-first-cycle window instead of later stages, the approach supports earlier escalation or de-escalation of NACT, and its exclusive reliance on DW-MRI facilitates protocol standardization, multi-centre deployment and privacy-preserving data sharing. These results demonstrate that DW-MRI-based deep learning on tumor-centered patches constitutes a minimally invasive, clinically deployable strategy for early pCR prediction, with direct implications for personalized treatment adaptation in neoadjuvant breast cancer therapy.

0.21

PolypVision: A Three-Stage Hierarchical Deep Learning Framework for Classification and Segmentation of Colorectal Polyps

cs.CV ·2026-08-11 ·Hamidreza Bolhasani, Hamidreza Rastad, Amir Mohammad Akbari, Mohammad Tashakoripour, Parnian Asadollahi +2 more
similarity 0.60
Abstract

Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide, predominantly arising from precancerous polyps. Accurate detection, segmentation, and endoscopic and histological classification of colorectal polyps are crucial for timely clinical intervention. In this study, we present PolypVision, a three-stage hierarchical deep learning framework that sequentially performs: (Stage 1) binary classification of polyps as adenomatous or hyperplastic, with simultaneous Paris and JNet classification, using EfficientNetV2-M with Focal Loss; (Stage 2) polyp segmentation with recommended resection method using a UNet++ decoder with the Stage 1 backbone as encoder, optimized with Dice and BCE losses; and (Stage 3) adenoma subtype classification (tubular, tubulovillous, villous) using EfficientNetV2-M with transfer learning from Stage 2. Evaluated on three public datasets -- PolypGen, Kvasir-SEG, and CVC-ClinicDB -- PolypVision achieves an AUC of approximately 0.99 for frame classification and a detection mAP@50 of 94.4% on Kvasir-SEG, outperforming or matching state-of-the-art methods. Gradient-weighted Class Activation Maps (Grad-CAM) confirm that the model attends to clinically relevant lesion features. The framework is device-independent, operating across diverse endoscopic imaging systems without hardware-specific adaptation. These results demonstrate that a hierarchical, transfer-learning-driven pipeline with task-specific loss functions offers a robust, device-independent, and clinically meaningful approach to automated colorectal polyp analysis. PolypVision is freely available as a web application at https://polypvision.com, a DataBioX initiative, with a free usage tier open to all users.

0.16

Potential of Artificial Intelligence Algorithms for Identification of Relevant Diagnostic and Prognostic Biomarkers of Early-Stage Liver Cancer

cs.AI ·2026-09-14 ·Ali Bou Nassif, Darko Castven, Manar Abu Talib, Jibran Sualeh Muhammad, Ahmed Ammar Kubba +2 more
hot direction similarity 0.59
Abstract · 25 pages, 11 figures, 4 tables, under review

This study explores the use of deep learning and explainable artificial intelligence to diagnose hepatocellular carcinoma (HCC) and define effective biomarkers across five different stages of disease development using a transcriptomic biomarker HCC dataset constructed via semi-supervised learning from three source datasets. Several deep learning experiments were conducted with different feature extraction techniques and gene sets to identify the most effective features for training high-accuracy models with minimal loss. The best-performing model, using 15 selected genes with the SelectKBest algorithm, achieved 90.74% accuracy, while the model with the lowest recorded loss of 0.3187 was obtained using 20 selected genes. To address the issue of class imbalance in the dataset, a weighted training approach was conducted, and for model transparency and interpretability a SHAP-based XAI analysis provided insights into the model's decision-making, consistently finding DNAJB14 as the most influential gene. Functional validation in this study has provided compelling evidence that DNAJB14 plays an important role in the adverse properties of HCC and that its inhibition effectively reverses tumour cell migration, invasion, colony and sphere formation. The main limitation of this study is the dataset's class imbalance, and while weighted training helped mitigate this, further research and additional data are needed to guarantee model generalizability. Future studies should also explore the influence of genetic variations, environmental factors, and clinical differences on model performance across diverse populations.

0.34